Cardiovascular Systems (CSII) Tops Q2 EPS by 6c, Revenues Miss; Offers 3Q Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
February 3, 2021 4:05 PM ESTConference Call Scheduled for Today, February 3, 2021, at 3:30 PM CT (4:30 PM ET)
Revenues of $64.2 million increased 6% sequentially compared to first quarter Net loss was $0.1 million, or $0.00 per basic and diluted share Management provides fiscal 2021 third quarter revenue guidance of $60 million to $65 million Receives CE Mark for Diamondback 360® Coronary Orbital Atherectomy System Sachin H. Jain, MD, MBA, joins Board of Directors Announces partnership to develop new drug-coated balloon technologyST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ:... More
